Aarti Pharmalabs Limited — Board Meeting, 07-08-2026: Outcome of Board Meeting
07-08-2026 | 07:59 pm
07-08-2026 | 07:59 pm
Aarti Pharmalabs' board approved Q1 consolidated results: Revenue Rs 535.79 Cr, PAT Rs 76.14 Cr. Rashesh C. Gogri designated MD and Hetal Gogri Gala as ED, effective Oct 1. A Rs 149 Cr capex for an Intermediate Block was also approved.
No comments yet. Be the first to comment!
